Meanwhile, the genes and proteins expressions of SIRT1/Nrf2 signaling pathway together with downstream factors including HO-1 and NQO1 were elevated in the YLZD treated NAFLD rats. This evidence concerns the gene NFE2L2 and metabolic dysfunction-associated steatotic liver disease.